Evidence map›Paper›PMID 35225284›Full record

ArticleJournal of visualized experiments : JoVE2022

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft.

Michelle Mendiola Pla, Amy Evans, Franklin H Lee, Yuting Chiang, Muath Bishawi, Andrew Vekstein, Lillian Kang, Diego Zapata, Ryan Gross, Alexis Carnes and 9 more

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. A porcine model of acute rejection for cardiac transplantation.Frontiers in cardiovascular medicine · 2025
    Article
  3. Article
  4. Delivery of a Muscle-Targeted Adeno-Associated Vector ViaTransplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  5. Article
  6. Human gene therapy · 2023
    Article
  7. Video analysis ofFrontiers in cardiovascular medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Michelle Mendiola PlaDivision of Cardiothoracic Surgery, Department of Surgery, Duke University.
Amy EvansPerfusion Services, Duke University.
Franklin H LeeDivision of Surgical Sciences, Department of Surgery, Duke University.
Yuting ChiangDivision of Cardiothoracic Surgery, Department of Surgery, Duke University.
Muath BishawiDivision of Cardiothoracic Surgery, Department of Surgery, Duke University.
Andrew VeksteinDivision of Cardiothoracic Surgery, Department of Surgery, Duke University.
Lillian KangDivision of Cardiothoracic Surgery, Department of Surgery, Duke University.
Diego ZapataDivision of Laboratory Animal Resources, Duke University.
Ryan GrossDivision of Surgical Sciences, Department of Surgery, Duke University.
Alexis CarnesPerfusion Services, Duke University.
Lynden E GaultGift of Hope Organ and Tissue Donor Network.
Julie A BalkoCollege of Veterinary Medicine, North Carolina State University.
Desiree BonadonnaPerfusion Services, Duke University.
Sam HoGift of Hope Organ and Tissue Donor Network.
Paul LezbergTransMedics, Inc.
Benjamin S BrynerDivision of Cardiothoracic Surgery, Department of Surgery, Duke University.
Jacob N SchroderDivision of Cardiothoracic Surgery, Department of Surgery, Duke University.
Carmelo A MilanoDivision of Cardiothoracic Surgery, Department of Surgery, Duke University; carmelo.milano@duke.edu.
Dawn E BowlesDivision of Surgical Sciences, Department of Surgery, Duke University; dawn.bowles@duke.edu.

Funding

MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
NHLBI NIH HHS T32 HL007101
6 · The paper itself

Abstract

Cardiac transplantation is the gold standard treatment for end-stage heart failure. However, it remains limited by the number of available donor hearts and complications such as primary graft dysfunction and graft rejection. The recent clinical use of an ex vivo perfusion device in cardiac transplantation introduces a unique opportunity for treating cardiac allografts with therapeutic interventions to improve function and avoid deleterious recipient responses. Establishing a translational, large-animal model for therapeutic delivery to the entire allograft is essential for testing novel therapeutic approaches in cardiac transplantation. The porcine, heterotopic heart transplantation model in the intraabdominal position serves as an excellent model for assessing the effects of novel interventions and the immunopathology of graft rejection. This model additionally offers long-term survival for the pig, given that the graft is not required to maintain the recipient's circulation. The aim of this protocol is to provide a reproducible and robust approach for achieving ex vivo delivery of a therapeutic to the entire cardiac allograft prior to transplantation and provide technical details to perform a survival heterotopic transplant of the ex vivo perfused heart.

Indexed as

Heart TransplantationAllograftsAnimalsGraft RejectionGraft SurvivalHumansSwineTissue DonorsTransplantation, Heterotopic

Identifiers

PMID35225284
PMCPMC10286737

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.